Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.78
0.0000
Post-market: 2.820.0400+1.44%16:25 EDT
Volume:632.42K
Turnover:1.76M
Market Cap:225.91M
PE:-2.82
High:2.86
Open:2.82
Low:2.75
Close:2.78
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:0.66
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:3.14
PE(LYR):-4.99

Loading ...

Eledon Pharmaceuticals Q1 Net Income USD -39.025 Million

THOMSON REUTERS
·
May 14

Eledon Pharmaceuticals Q1 Basic EPS USD -0.33

THOMSON REUTERS
·
May 14

Press Release: Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
May 14

Eledon Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 08

Eledon Pharmaceuticals Files $500 Million Mixed Shelf Registration

MT Newswires Live
·
May 02

Eledon Pharmaceuticals files $500M mixed securities shelf

TIPRANKS
·
May 02

Newcelx Reports Financial Results for 2025 and Provides Shareholders With Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration With Eledon Pharmaceuticals in 2026

THOMSON REUTERS
·
Apr 30

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

Benzinga Earnings
·
Apr 30

Eledon Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 21

NewcelX publishes updated corporate presentation

Reuters
·
Apr 20

Is Eledon Pharmaceuticals (NASDAQ:ELDN) In A Good Position To Deliver On Growth Plans?

Simply Wall St.
·
Mar 24

Eledon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 20

Corrected-Eledon Pharmaceuticals: FY (Not 'Q4') EPS $-0.52

THOMSON REUTERS
·
Mar 20

Eledon Pharmaceuticals 2025 net loss widens on higher R&D costs

Reuters
·
Mar 20

Eledon Pharma Q4 EPS $(0.10) Beats $(0.18) Estimate

Benzinga Earnings
·
Mar 20

Eledon Pharmaceuticals FY Operating Expenses USD 83.251 Million

THOMSON REUTERS
·
Mar 20

Press Release: Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Dow Jones
·
Mar 20

Eledon Pharmaceuticals: Q4 EPS $-0.52

THOMSON REUTERS
·
Mar 20

Eledon FY 2025 net loss was USD 45.6 million as R&D expenses rose 27.5% to USD 66.3 million

Reuters
·
Mar 20

Eledon Pharmaceuticals options imply 11.7% move in share price post-earnings

TIPRANKS
·
Mar 20